Wells Fargo & Company Amneal Pharmaceuticals, Inc. Transaction History

Wells Fargo & Company

$433 Billion
Q4 2024

A detailed history of Wells Fargo & Company transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 77,973 shares of AMRX stock, worth $607,409. This represents 0.0% of its overall portfolio holdings.

Number of Shares

77,973

Previous 177,835 56.15%

Holding current value

$607,409

Previous $1.48 Million 58.28%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	SELL	$7.69 - $9.25 $767,938 - $923,723	-99,862 Reduced 56.15%	77,973 $617,000
Q3 2024 Nov 13, 2024	BUY	$6.42 - $8.83 $760,705 - $1.05 Million	118,490 Added 199.66%	177,835 $1.48 Million
Q2 2024 Aug 13, 2024	BUY	$5.36 - $7.11 $58,247 - $77,264	10,867 Added 22.42%	59,345 $376,000
Q1 2024 May 10, 2024	BUY	$5.24 - $6.34 $54,296 - $65,695	10,362 Added 27.19%	48,478 $293,000
Q4 2023 Feb 09, 2024	BUY	$3.36 - $6.21 $23,089 - $42,675	6,872 Added 21.99%	38,116 $231,000
Q3 2023 Nov 13, 2023	SELL	$2.76 - $4.59 $69,723 - $115,952	-25,262 Reduced 44.71%	31,244 $131,000
Q2 2023 Aug 15, 2023	BUY	$1.33 - $3.1 $45,773 - $106,689	34,416 Added 155.8%	56,506 $175,000
Q1 2023 May 12, 2023	BUY	$1.27 - $2.7 $26,516 - $56,373	20,879 Added 1724.11%	22,090 $30,000
Q4 2022 Feb 13, 2023	SELL	$1.96 - $2.61 $24,795 - $33,019	-12,651 Reduced 91.26%	1,211 $2,000
Q3 2022 Nov 14, 2022	SELL	$2.02 - $3.62 $2,266 - $4,061	-1,122 Reduced 7.49%	13,862 $28,000
Q2 2022 Aug 12, 2022	SELL	$3.01 - $4.46 $667,672 - $989,308	-221,818 Reduced 93.67%	14,984 $48,000
Q1 2022 May 16, 2022	SELL	$3.9 - $4.89 $589,293 - $738,883	-151,101 Reduced 38.95%	236,802 $988,000
Q4 2021 Feb 14, 2022	SELL	$3.95 - $5.85 $1.45 Million - $2.15 Million	-366,788 Reduced 48.6%	387,903 $1.86 Million
Q3 2021 Nov 15, 2021	SELL	$4.31 - $5.64 $516,825 - $676,309	-119,913 Reduced 13.71%	754,691 $4.03 Million
Q2 2021 Aug 16, 2021	BUY	$5.12 - $6.82 $209,008 - $278,406	40,822 Added 4.9%	874,604 $4.48 Million
Q1 2021 May 13, 2021	BUY	$4.74 - $7.38 $2.36 Million - $3.67 Million	497,351 Added 147.83%	833,782 $5.61 Million
Q4 2020 Feb 09, 2021	SELL	$3.95 - $5.42 $140,983 - $193,450	-35,692 Reduced 9.59%	336,431 $1.54 Million
Q3 2020 Nov 05, 2020	BUY	$3.54 - $5.27 $223,458 - $332,663	63,124 Added 20.43%	372,123 $1.45 Million
Q2 2020 Aug 13, 2020	BUY	$2.87 - $5.46 $271,711 - $516,914	94,673 Added 44.17%	308,999 $1.47 Million
Q1 2020 May 14, 2020	BUY	$2.46 - $5.35 $527,241 - $1.15 Million	214,326 New	214,326 $746,000

Others Institutions Holding AMRX

# of Institutions

205

Shares Held

123M

Call Options Held

362K

Put Options Held

141K

View Full List

About Amneal Pharmaceuticals, Inc.

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.18B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

More about AMRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Amneal Pharmaceuticals, Inc. Transaction History